Prostate cancer: open trials in Israel

19 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Emek Medical Center ( Site 0830), Afula · Rambam Health Care Campus-Oncology Division ( Site 0826), Haifa · Hadassah Medical Center ( Site 0833), Jerusalem · Meir Medical Center. ( Site 0832), Kfar Saba · Rabin Medical Center ( Site 0828), Petah Tikva · Sheba Medical Center ( Site 0827), Ramat Gan
Registry updated 2026-11-05
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Carmel Medical Center, Haifa · Rambam Med.Center - Hematology Institute, Haifa · Rambam Medical Center, Haifa · Hadassah University Hospita Ein Kerem, Jerusalem · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-04
NCT07746713
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Rambam Health Care Campus, Haifa · Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-03
NCT07906717
A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Rambam Medical Center, Haifa
Registry updated 2026-11-03
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Rambam Health Care Campus ( Site 0462), Haifa · Shaare Zedek Medical Center ( Site 0468), Jerusalem · Meir Medical Center ( Site 0464), Kfar Saba · Rabin Medical Center ( Site 0461), Petah Tikva · Sheba Medical Center ( Site 0460), Ramat Gan · Sourasky Medical Center ( Site 0463), Tel Aviv · Yitzhak Shamir Medical Center. ( Site 0466), Tsrifin
Registry updated 2026-10-30
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Beersheba · Haifa · Jerusalem · Petah Tikva · Tel Aviv
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Emek Medical Center ( Site 0680), Afula · Rambam Health Care Campus-Oncology Division ( Site 0676), Haifa · Shaare Zedek Medical Center ( Site 0679), Jerusalem · Hadassah Medical Center ( Site 0683), Jerusalem · Meir Medical Center. ( Site 0682), Kfar Saba · Rabin Medical Center ( Site 0678), Petah Tikva · Sheba Medical Center ( Site 0677), Ramat Gan · Sourasky Medical Center ( Site 0681), Tel Aviv
Registry updated 2026-10-20
NCT07344779
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-19
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Haifa · Jerusalem · Petah Tikva · Ramat Gan · Tel Aviv
Registry updated 2026-10-19
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Afula · Beersheba · Hadera · Haifa · Jerusalem · Kfar Saba · Nahariya · Petah Tikva · Ramat Gan · Tel Aviv
Registry updated 2026-10-14
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Rambam Health Care Campus, Haifa · Shaare Zedek Medical Center, Jerusalem · Hadassah medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Sourasky Medical Center, Tel Aviv · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-10-14
NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus ( Site 0400), Haifa · Hadassah Medical Center ( Site 0404), Jerusalem · Rabin Medical Center ( Site 0402), Petah Tikva · Sheba Medical Center ( Site 0401), Ramat Gan · Sourasky Medical Center ( Site 0403), Tel Aviv
Registry updated 2026-10-09
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Beersheba · Haifa · Jerusalem · Petah Tikva · Tel Aviv · Tsrifin
Registry updated 2026-10-01
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Beersheba · Haifa · Jerusalem · Petah Tikva · Ramat Gan · Tel Aviv
Registry updated 2026-09-22
NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Trial Treatment · Phase 2 · GlaxoSmithKline
Haifa
Registry updated 2026-06-24
NCT06202248
Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
Trial Treatment · Alpha Tau Medical LTD.
Rambam Health Care Campus, Haifa
Registry updated 2026-06-16
NCT07208240
Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.
Trial Treatment · Phase 1/2 · Rabin Medical Center
Beilinson Hospital, Petah Tikva
Registry updated 2025-10-06
NCT05560659
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
Trial Treatment · Phase 2 · Peter MacCallum Cancer Centre, Australia
Sheba Medical Centre, Tel Aviv
Registry updated 2025-07-11
NCT06027892
Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
Trial Treatment · Rabin Medical Center
Davidoff Cancer Center, Rabin Medical Center, Petah Tikva
Registry updated 2024-11-15

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error